(redirected from Formoterol)
Also found in: Dictionary, Medical, Wikipedia.
Related to Formoterol: Foradil
FORMFirst Order Reliability Method
FORMFeature-Oriented Reuse Method
FORMFamily Occupation Recreation Money
FORMFamily, Occupation, Recreation, Message
FORMFoundation for Organic Resources Management, Inc. (Fayetteville, AR)
References in periodicals archive ?
4% of predicted value, at least one exacerbation in the past 12 months) to receive either nebulized formoterol 20 mcg/2 mL twice daily or matching placebo for up to 12 months.
The prolonged activity of formoterol is also thought to be due to its lipophilicity, although formoterol is less lipophilic than salmeterol.
The three groups were categorized as R1 (morning tiotropium + evening placebo-matched for formoterol), R2 (morning tiotropium and formoterol + evening placebo-matched for formoterol), and R3 (morning tiotropium and formoterol + evening formoterol).
On the first test day, after a 30-min rest, baseline measurements just prior to the administration of single dose of 12 [micro]g formoterol via the Aerolizer[R] were recorded.
The studies were supported by AstraZeneca, which manufactures budesonide and formoterol under the brand name Symbicort.
The product is an approved fixed-dose LAMA/LABA combination of two long-acting bronchodilators, including aclidinium bromide and formoterol fumarate.
ORLANDO - A combination of fixed-dose mometasone furoate and formoterol fumarate improved lung function in patients with moderate to very severe chronic obstructive pulmonary disease.
They found that the drug formoterol, used to treat asthma and lung diseases, increases metabolism and fat burning in adults who are at rest.
has received Food and Drug Administration approval for Dulera (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol, a fixed-dose combination asthma treatment for patients age 12 and older.
9, 2008, and is directed to treatment through the administration of a ready-to-use, storage stable composition of formoterol.
In addition, an analysis of these trials showed that patients receiving SYMBICORT achieved a bronchodilatory effect, or opening of the airways, similar to formoterol DPI, and a more rapid effect than that achieved by either budesonide pMDI or placebo.
The new product--a combination of the corticosteroid budesonide and formoterol (in formulations of 80/4.